Annovis Bio Inc (NYSE: ANVS) on Monday, soared 29.49% from the previous trading day, before settling in for the closing price of $2.34. Within the past 52 weeks, ANVS’s price has moved between $1.11 and $7.52.
A company in the Healthcare sector has dropped its sales by -73.95% annually for the last half of the decade. The company achieved an average annual earnings per share of 41.67%. With a float of $22.47 million, this company’s outstanding shares have now reached $26.50 million.
Annovis Bio Inc (ANVS) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Annovis Bio Inc is 11.09%, while institutional ownership is 11.40%. The most recent insider transaction that took place on Oct 28 ’25, was worth 200,000. In this transaction President & CEO of this company bought 97,561 shares at a rate of $2.05, taking the stock ownership to the 1,212,020 shares. Before that another transaction happened on Oct 28 ’25, when Company’s Director bought 975,610 for $2.05, making the entire transaction worth $2,000,000. This insider now owns 2,455,539 shares in total.
Annovis Bio Inc (ANVS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 41.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.40% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Annovis Bio Inc (ANVS) is currently performing well based on its current performance indicators. A quick ratio of 4.60 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Let’s dig in a bit further. During the last 5-days, its volume was 9.48 million. That was better than the volume of 0.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 65.24%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 60.08%, which indicates a significant increase from 54.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.16, while its 200-day Moving Average is $2.19. However, in the short run, Annovis Bio Inc’s stock first resistance to watch stands at $3.90. Second resistance stands at $4.77. The third major resistance level sits at $5.55. If the price goes on to break the first support level at $2.26, it is likely to go to the next support level at $1.48. Assuming the price breaks the second support level, the third support level stands at $0.61.
Annovis Bio Inc (NYSE: ANVS) Key Stats
Market capitalization of the company is 80.31 million based on 26,503K outstanding shares. Right now, sales total 0 K and income totals -24,590 K. The company made 0 K in profit during its latest quarter, and -6,220 K in sales during its previous quarter.
